InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,410.94
(
1.25%
)
US TECH 100
18,398.00
(
1.90%
)
Dow Jones
39,650.64
(
0.75%
)
Brent Oil
80.43
(
-1.45%
)
Bitcoin
59,943.61
(
0.99%
)
Post# of 252867
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

ThomasS

Send PM Follow Ignore
Followers 12
Posts 2277
Boards Moderated 0
Alias Born 05/05/2005

ThomasS

Re: DewDiligence post# 115930

Sunday, 03/06/2011 6:28:23 PM

Sunday, March 06, 2011 6:28:23 PM

Post# of 252867
MNTA: "Therefore, the fact that Teva has agreed to a drawn-out timeline in which a trial could not start until 2013 suggests that Teva has no expectation of getting FDA approval in the next two years."

I believe what may be lost in this discussion is the obvious fact that NVS/MNTA must also have no expectation of Teva garnering an imminent approval. Didn't NVS/MNTA have to agree to the timeline?

"If we don't succeed, we run the risk of failure."
-Dan Quayle

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up